Trademark: 90211312
Word
LUMISIGHT
Status Date
Monday, July 1, 2024
Filing Date
Friday, September 25, 2020
Published for Opposition
Tuesday, March 30, 2021
Abandoned Date
Monday, July 1, 2024
5 pharmaceutical preparations for the diagnosis and treatment of cancer and illnesses and conditions, namely, cancer and precancerous lesions
Sep 29, 2020
New Application Entered
Feb 19, 2021
Approved For Pub - Principal Register
Nov 5, 2020
New Application Office Supplied Data Entered
Feb 16, 2021
Assigned To Examiner
Mar 10, 2021
Notification Of Notice Of Publication E-Mailed
Mar 30, 2021
Published For Opposition
Mar 30, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 13, 2022
Sou Extension 2 Granted
Nov 3, 2021
Sou Teas Extension Received
Nov 3, 2021
Sou Extension 1 Filed
Nov 3, 2021
Sou Extension 1 Granted
Nov 5, 2021
Notice Of Approval Of Extension Request E-Mailed
Apr 13, 2022
Sou Teas Extension Received
Apr 13, 2022
Sou Extension 2 Filed
Nov 2, 2022
Sou Extension 3 Filed
Apr 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Teas Extension Received
Nov 2, 2022
Sou Extension 3 Granted
Nov 7, 2023
Sou Extension 5 Granted
Nov 4, 2022
Notice Of Approval Of Extension Request E-Mailed
May 10, 2023
Sou Teas Extension Received
May 10, 2023
Sou Extension 4 Filed
May 10, 2023
Sou Extension 4 Granted
May 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 1, 2023
Sou Teas Extension Received
Nov 1, 2023
Sou Extension 5 Filed
Nov 7, 2023
Case Assigned To Intent To Use Paralegal
Jul 1, 2024
Abandonment - No Use Statement Filed
Jul 12, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
